Is severe depression a separate indication?

Author： Montgomery S.A.   Lecrubier Y.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.9, Iss.3, 1999-03, pp. : 259-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mirtazapine, fluoxetine comparable for severe depression

By  

Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Understanding impulsivity in severe depression? A psychometrical contribution

By Corruble E.   Benyamina A.   Bayle F.   Falissard B.   Hardy P.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 829-833

Elsevier

Access to resources Recommend Favorite

Venlafaxine ER switch beneficial in severe depression

By  

Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Long-term escitalopram beats paroxetine for severe depression

By  

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Severe Depression: Is There a Best Approach?

By Sonawalla S.B.   Fava M.  

CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite